SCHEMBL7985165

SCHEMBL7985165

Cc1ccc(Cn2cnc3nc(-c4ccc(F)cc4)nc(O)c32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.47
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
KDM4E B2RXH2 3/20 0.40
F2 P00734 2/20 0.39
RAB9A P51151 1/20 0.39
THRB P10828 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
HDAC6 Q9UBN7 2/20 0.38
HDAC8 Q9BY41 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
HTT P42858 1/20 0.38
SOS1 Q07889 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
MAPK14 Q16539 1/20 0.37
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984281 0.94 MET (0.52) METKMT2AKDM4EHDAC6SMN1; SMN2
SCHEMBL7985060 0.89 ADORA2A (0.39) METKDM4EF2RAB9AHDAC6
SCHEMBL7986521 0.88 CYP11B1 (0.47) METKMT2AMEN1KDM4ERAB9A
SCHEMBL7984717 0.88 SMN1; SMN2 (0.46) KMT2AMEN1RAB9AHDAC6HDAC8
SCHEMBL7974507 0.88 MET (0.46) METKMT2AKDM4ESMN1; SMN2CYP11B1
SCHEMBL7987361 0.88 MET (0.45) METRAB9AHDAC6MAPK14MAPT
SCHEMBL7985826 0.87 NPC1 (0.41) METKMT2AMEN1KDM4ERAB9A
SCHEMBL7985275 0.87 MET (0.46) METHDAC6HDAC8CYP11B1CYP11B2
SCHEMBL7974469 0.87 HDAC1 (0.40) METKMT2AMEN1KDM4ERAB9A
SCHEMBL7988567 0.87 HPGD (0.44) METKMT2AMEN1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed